Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure

Nephron

Volumn 77, Issue 3, 1997, Pages 315-318

  Ifudu, Onyekachi ^a   Dawood, Mohammed ^a   Friedman, Eli A ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Anemia; Chronic renal failure; Erythropoietin; Gastrointestinal bleeding; Hemodialysis; Impaired utilization; Iron; Iron deficiency; Serum creatinine

Indexed keywords

CREATININE; ERYTHROPOIETIN; FERRITIN; IRON; TRANSFERRIN; UREA;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OCCULT BLOOD; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA;

EID: 0030725554     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190294     Document Type: Article

References (19)

1. Gotloib L, Ludicer H, Mines M, Ackerman J: Iron storage in chronic uremic undialysed patients. Dial Transplant 1983:12:442B-442E.
2. Boddy K, Lawson DH, Linton AL, Will G: Iron metabolism in patients with chronic renal failure. Clin Sci 1970:39:115-121.
3. Akmal M, Sawelson S, Karubian F. Gadallah M: The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure or receiving dialyt-ic therapy. Clin Nephrol 1994:42:198-202.
4. Zuckerman GR, Comette GL, Clouse RF, Harter HR: Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 1985;102:588-592.
5. Muirhead N, Cattran DC, Zaltzman J, et al: Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction. J Am Soc Nephrol 1994;5:1216-1222.
6. Silverberg DS, Iaina A, Peer G, et al: Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996:27:234-238.
7. Norusis MJ: SPSS for windows: Advanced statistics. release 6.0. Chicago. Statistical Package for Social Sciences, 1993. pp 1-30.
8. Ifudu O, Dawood M, Homel P, Friedman FA: Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996;28:841-845.
9. Ifudu O, Dawood M, Homel P, Friedman EA: Timing of initiation of uremia therapy and survival in patients with progressive renal disease. Am J Nephrol, in press.
10. Cammata JB, Gomez-Alonso C, et al: Iron uptake in aluminum overload: In vivo and in vitro studies. Nephrol Dial Transplant 1991;6: 637-642.
11. Wauters JP: Iron requirements: To whom and when (abstract). XUIth International Congress of Nephrology, Madrid. July 2-6. 1995.
12. Sepandj F, Jindal K, West M, Hirseh D: Economic appraisal of maintenance parenteral iron administration in treatment of anemia in chronic hemodialysis patients. Nephrol Dial Transplant 1996,11:319-322.
13. Stewart WK, Fleming LW, Shepherd AMM: Hemoglobin and scrum iron responses to periodic intravenous iron dextran infusions during maintenance hemodialysis. Nephrol 1976; 17: 121-130.
14. Sivcrberg DS, Blum M, Peer G, Kaplan E, Iaina A: Intravenous ferrum saccharale as an iron supplement in dialysis patients. Nephron 1996: 72:413-417.
15. Fishbane S, Lynn RI: The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. Clin Nephrol 1995:44: 238-240.
16. Fishbane S, Frei GL, Maesaka J: Reduction in rHuEPO doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995,26:41-46.
17. Fairbanks VF, Beutler E: Iron deficiency; in Beutler E. Lichtman MA. Coller BS. Kipps TJ (cds): Williams Hematology. New York. McGraw-Hill. 1995. pp 490-509.
18. Cantinieaux B, Hariga C, Fcrstcr A, et al: Neutrophil dysfunctions in thalassemia major: The role cf cell iron overload. EurJ Haematol 1987; 39:28-34.
19. Stevens RG, Jones DY, Micozzi MS, Taylor PR: Body iron stores and the risk of cancer. N Engl J Med 1988:319:1047-1052.